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Abstract A disulfide-rich, low-molecular-mass toxin-like pep-
tide has been isolated from Parabuthus schlechteri venom using
gel filtration, ion exchange, and reversed phase chromatography.
Partial characterization of this peptide reveals a relationship
with four-disulfide bridge proteins belonging to the family of
‘short’ insectotoxins (44% residue identity). In recognition
hereof, the peptide was named PBITx1 (sITx10). Our work
also reports on the deduced sequences of two other ‘short’
insectotoxins from Buthus eupeus, I3 and I4, and it provides a
consensus sequence and nomenclature for all known ‘short’
insectotoxins. Finally, sequence similarities with K+ channel
blockers (charybdotoxin, U-conotoxin), and a Cl3 channel
blocker (chlorotoxin) are highlighted.
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1. Introduction
Venoms of insects, scorpions, snakes and other species pro-
vide a rich source of molecules that can interact with mem-
brane receptors and ion channels with high a⁄nity and selec-
tivity. It is well known that scorpion venoms contain a variety
of peptides toxic to man [1], insects [2], and crustaceans [3,4].
These toxins isolated from the venom are useful tools for
probing the structures of di¡erent ion channels and evaluating
their physiological contribution to cell and organ behavior. In
addition, elucidation of their mechanisms of action, knowl-
edge of their three-dimensional structure and the discovery
of common sca¡olds between sometimes unrelated toxins
open wide perspectives in designing various drugs [5].
In general, scorpion toxins can be divided into two main
groups according to their molecular size. The ¢rst group rep-
resents the long-chain toxins with 60^70 residues cross-linked
by four disul¢de bridges. Most of these toxins a¡ect voltage-
dependent Na channels in excitable cells [6,7]. The second
group contains the short-chain toxins with 30^40 residues
cross-linked by three or four disul¢de bridges. Their toxicity
is based on potent block of several types of K channels,
voltage-dependent and calcium-activated, in a wide variety
of cell types [8,9]. Some of the scorpion toxins belonging to
the ¢rst group display high selectivity towards animals be-
longing to di¡erent phyla [10]. For instance, AaHIT from
Androctonus australis hector [11] and LqhIT2 from Leiurus
quinquestriatus hebraeus [12] are insect-selective Na channel
toxins, respectively with an excitatory and depressant e¡ect.
These toxins are also called ‘long’ insectotoxins (ITs) and were
recently reviewed together with the large family of mamma-
lian-selective Na channel toxins [7]. ‘Short’ insectotoxins
have been reported in the literature as well, based on the
selective paralytic activity on insects of these V4 kDa pep-
tides [13]. Analogous structures have been labeled accordingly
later on, but sometimes they are also called ‘toxin-like’ pep-
tides. In any case, ‘short’ insectotoxins have received much
less attention in the past than the ‘long’ chain toxins, since
(i) the number of well-characterized ‘short’ insectotoxins
known today is limited (fewer than 10 ‘short’ versus more
than 50 ‘long’ chain insectotoxins), (ii) the solution structure
by NMR has only been determined for I5A [14], chlorotoxin
[15], and Lqh-8/6 [16], and (iii) the biological function mostly
remains unknown. In fact, only for chlorotoxin, a basic pep-
tide of V4 kDa with considerable sequence identity to ‘short’
insectotoxins and puri¢ed from the venom of Leiurus quin-
questriatus quinquestriatus, has block of small-conductance
Cl3 channels been reported [17].
Here we report the puri¢cation and partial characterization
of a ‘short’ insectotoxin-like peptide in the venom of the scor-
pion Parabuthus schlechteri, a species occurring in southern
Africa. During investigation of other short-chain toxins active
on voltage-dependent K channels, such as PBTx1 from
Parabuthus transvaalicus and PBTx2 from Parabuthus villosus
[18,19], we discovered by chance in the venom of P. schlechteri
a ‘short’ insectotoxin-like peptide, which we named PBITx1
(sITx10, see further). Although the biological activity and the
C-terminal part of PBITx1 could not be determined yet (be-
cause of lack of material), the high level of sequence identity
between PBITx1 and other ‘short’ insectotoxins is evident.
This work also reports on the deduced sequences of two other
‘short’ insectotoxins from the venom of the scorpion Buthus
eupeus, I3 and I4 [20], and it provides a consensus sequence
and uniform nomenclature for all known ‘short’ insectotoxins.
The similarities between PBITx1 and chlorotoxin suggest that
Cl3 channels could be the peptides’ natural target.
2. Materials and methods
2.1. Venom collection
P. schlechteri scorpions were captured in South Africa. Venoms
were collected by electrical stimulation and lyophilized after dilution
in a saline bu¡er or distilled water.
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2.2. Venom puri¢cation
Lyophilized venom was dissolved in 100 mM ammonium acetate,
pH 7 (Merck, Germany). After vortexing, the sample was clari¢ed by
centrifugation at 14 000 rpm for 15 min and its supernatant was then
applied onto a Superdex 30 prep grade HiLoad 16/60 FPLC column
(Pharmacia LKB Biotech, Sweden) equilibrated with 100 mM ammo-
nium acetate, pH 7. The material was eluted with the same bu¡er at a
£ow rate of 0.2 ml/min. Absorbance of the eluate was monitored at
280 nm and 4 ml fractions were collected automatically. The fraction
containing PBITx1 was recovered, lyophilized and applied on a
PepRPC HR 5/5 C2/C18 reversed phase FPLC column (Pharmacia,
Sweden) equilibrated with 0.1% tri£uoroacetic acid (TFA) in distilled
water. Separation was performed by using a linear gradient of 0^100%
acetonitrile (supplemented with 0.1% TFA) for 60 min. The £ow rate
was 0.5 ml/min and the absorbance was measured at 214 nm. Frac-
tions eluting at 20^27 min with potential short-chain toxins were
recovered, dried (Speed Vac Plus, Savant, USA), and applied on a
monomeric 238TP54 C18 reversed phase HPLC column (Vydac, USA)
equilibrated with 0.1% TFA in distilled water. Separation was per-
formed with the following gradient: after 4 min an immediate step to
5% acetonitrile (supplemented with 0.1% TFA), followed by a linear
gradient to 30% acetonitrile for the next 5 min, and a linear gradient
to 60% for the last 11 min (total run: 20 min). The £ow rate was 0.75
ml/min and the absorbance was simultaneously measured at 214, 254
and 280 nm. The fraction containing PBITx1 was recovered, dried
(Speed Vac Plus, Savant, USA), and applied to a Mono S PC 1.6/5
cation exchange HPLC column (Pharmacia, Sweden) equilibrated
with 50 mM phosphate bu¡er, pH 6.8. Separation was performed
using a linear gradient of 0^100% 1 M NaCl (supplemented with 50
mM phosphate bu¡er, pH 6.8). The £ow rate was 0.1 ml/min and the
absorbance was simultaneously measured at 214, 254 and 280 nm.
Desalting of the material was performed with the monomeric
238TP54 C18 reversed phase HPLC column (Vydac, USA) using the
same experimental reversed phase conditions as above. Additional
con¢rmation of sample purity was accomplished by application of
the peptide to a 218TP104 C18 analytical reversed phase column (Vy-
dac, USA). A gradient of 0^60% acetonitrile in the presence of 0.1%
TFA was run for 60 min. The component eluting at 25.32 min cor-
responded to the pure peptide and was used for sequence determina-
tion.
2.3. Sequence determination
The automated Edman degradation procedure was used in a Beck-
man LF3000 protein sequencer. Approximately 50 pmol of pure
PBITx1 peptide was loaded into the sequencer. Unequivocal sequence
was obtained for the 22 amino acid residues located at the N-terminal
segment of the native peptide.
3. Results and discussion
Crude venom was fractionated by gel ¢ltration as detailed
in Section 2 to produce three typical groups of components
(Fig. 1A). The occurrence of three groups is reminiscent of the
venom fractionation of another closely related Parabuthus
scorpion, P. transvaalicus. This observation points to a clear
interspecies relationship within the genus, corroborating our
previous work [18]. In our quest of ¢nding novel short-chain
toxins in the venom active on voltage-dependent K channels,
such as PBTx1 from P. transvaalicus and PBTx2 from P.
villosus [18,19], we recovered fractions eluting at 20^27 min
during the reversed phase FPLC run (Fig. 1B). Final puri¢-
cation of PBITx1 was achieved by means of consecutive re-
versed phase, cation exchange and again reversed phase
HPLC runs (Fig. 1C^E). Although the same and typical gel
¢ltration ¢ngerprint was obtained for the P. schlechteri scor-
pions used in this study (n = 9), regardless of milking time
interval and span in captivity, it was found that the presence
of PBITx1 in the venom of this species was very scarce and
that PBITx1 represents only a minor fraction of the venom
constituents. In fact, the only successful isolation we have
FEBS 21336 30-12-98
Fig. 1. Puri¢cation of PBITx1 from Parabuthus schlechteri venom.
A: Crude venom was ¢rst fractionated by FPLC gel ¢ltration as in-
dicated in Section 2, yielding three typical groups of peaks (I^III).
The labeled fraction (D) in group I was recovered and lyophilized.
Based on a constructed gel ¢ltration calibration curve, the molecular
mass of the material in this fraction ranged from 3 to 6 kDa [18].
B: The second puri¢cation step was carried out using a FPLC
C2/C18 reversed phase column. Fractions eluting at 20^27 min (D)
with ‘potential’ short-chain toxins were recovered and dried. C: The
third step involved a HPLC C18 reversed phase puri¢cation. The
labeled fraction (D) was recovered and dried. D: Cation exchange
puri¢cation step on a Mono S HPLC column. The labeled fraction
(D) was recovered. E: Final puri¢cation and desalting on a HPLC
C18 reversed phase column. See Section 2 for experimental details
during the di¡erent puri¢cation steps.
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been able to carry out was achieved with V100 mg crude
venom pooled from di¡erent animals. PBITx1 yield from
this starting material was V1.5 Wg (0.0015%), as judged
from the absorbance measured at 280 nm and taking into
account the molar extinction coe⁄cient of peptide I, a highly
homologous peptide isolated from Buthus sindicus [21].
The primary amino acid sequence of PBITx1 was deter-
mined as detailed in Section 2. Most of the positions were
unequivocally assigned. It is known that cysteine residues
are di⁄cult to identify, unless the sample is alkylated before-
hand. However, blank spaces in a clear sequence mean the
presence of a cysteinyl residue, which is the case for positions
2, 5, 16 and 20 in PBITx1. Position 19 could be either a
cysteine or an aspartic acid. The di⁄culty in assigning posi-
tion 19 arises from the fact that the previous residue at posi-
tion 18 is also an aspartic acid. Additionally, position 23 is
either an arginine or a glycine. Again the de¢nitive assignment
of this position is hampered by the preceding double glycines
at positions 21 and 22. Finally, the last amino acid identi¢ed
at position 25 is very likely a lysine.
Comparison of these data with other closely related ‘short’
insectotoxin-like peptides is shown Fig. 2. When cysteine res-
idues are aligned, a search for sequence identity shows a close
relationship with insectotoxins I1, I5 and I5A from B. eupeus
(44, 64, 64% respectively) [13,20], AmmP2 from Androctonus
mauretanicus (56%) [2,6], peptide I from B. sindicus (88%) [21],
chlorotoxin from L. quinquestriatus quinquestriatus (60%) [17]
and Lqh-8/6 from L. quinquestriatus hebraeus (68%) [16]. If
residue 23 of PBITx1 is an arginine, it resembles toxin I1 and
AmmP2; if it is glycine, it is rather similar to I5.
Another common feature is the net charge of these ‘short’
insectotoxins, ranging from +2 to +5, making them basic
peptides. The strong retention of PBITx1 seen on a cation
exchange column (Fig. 1D) con¢rms the peptide’s basic char-
acter.
We also provide here the deduced sequences of two insec-
totoxins, I3 and I4, from the venom of the scorpion B. eupeus
living in Central Asia to highlight the high degree of identity
with I1, I5 and I5A. Almost 15 years ago, the amino acid
composition of ¢ve ‘short’ insectotoxins (I1, I3, I4, I5 and
I5A) from B. eupeus was published, together with the complete
sequences of I1, I5 and I5A [20]. For I4, sequence information
was available for as far as eight N-terminal residues, whereas
no sequence has ever been reported for I3. Thanks to the
amino acid analysis data of Ovchinnikov [20] and the strong
conservation in primary structure of the ‘short’ insectotoxins
in general, a theoretical sequence analysis as outlined below
made it possible to predict the most plausible sequences for I3
(36 aa) and I4 (35 aa) (see Fig. 2). Our strategy was the
following: (i) alignment of the cysteine residues (eight resi-
dues), (ii) ¢ll in the 100% conserved N- and C-terminal re-
gions (in single letter code: MCMPCFTT and KCFG-QCLC,
respectively, yielding 11 additional residue positions), (iii) ¢ll
in three other 100% conserved positions (A13, R17 and G22),
and (iv) conclusion of the sequence by comparing identical
and homologous positions between all ‘short’ insectotoxins
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Fig. 2. Partial amino acid sequence of PBITx1. The primary structure (in single letter code) of PBITx1 is compared with similar ‘short’ insecto-
toxins, after manual alignment of the cysteine residues. The consensus sequence is given below. For the 10 similar sequences known thus far, a
uniform nomenclature is proposed: the family of sITx peptides (from short insectotoxin). Numbering within this family has been assigned ac-
cording to date of publication. Therefore, peptide I1 and PBITx1 are designated sITx1 and sITx10, respectively. The percentage identity be-
tween these peptides is also shown, either as compared to peptide I1 (left column), or as compared to PBITx1 (right column). The net charge
of the insectotoxins ranges from +2 to +5, indicating that they are basic molecules at physiological pH. The pattern of disul¢de bridges deter-
mined for I5A [14], chlorotoxin [15], and Lqh-8/6 [16] is indicated. Regions of secondary structures: K-helix (gray bar) and two antiparallel L-
strands (black bar). Sequences for I3 (D) and I4 (DD), which are deduced sequences, are shown in italics and are based on amino acid analysis
results combined with clear sequence identity (s 50%) with I1, I5 and I5A (see also text) [20]. For peptide I4, residues at positions 14 and 23
are shown in small caps because we cannot exclude a reversed occurrence in the native peptide.
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(e.g. for I3 : D9 (90%), H10 (30%), Q11 (50%), T12 (20%), R14
(60%), R15 (90%), D18 (80%), G21 (90%), R23 (60%), G24
(50%), R25 (60%), and GYD with I1 (100%)). The analysis
carried out above, together with the published sequences, en-
abled us to compose a list of all ‘short’ insectotoxins known
thus far and to derive a consensus sequence (see Fig. 2). To-
gether with the eight cysteine residues, eight other residues
were found to be 100% conserved for the 10 members of
‘short’ insectotoxins.
On this occasion, we also propose a uniform nomenclature
for these peptides, representing a dramatic improvement in
the naming of the ever expanding family of short-chain toxins
in general over the ‘whimsical’ names currently in use. By
analogy with Miller’s nomenclature for K channel blocking
toxins, K-KTx [22], we propose to use the name sITx (from
short insectotoxin). Thus, instead of using the biological ac-
tion on ion channels to designate ‘short’ insectotoxins, such as
chlorotoxin [17], or using fraction numbers, like Lqh-8/6 [16],
these peptides can be labeled much more easily sITx8 and
sITx9, respectively. Using this nomenclature, PBITx1 corre-
sponds to sITx10. Our consensus sequence, as well as our
nomenclature, might be a useful tool for future classi¢cation
and systematic comparison of the ever growing number of
novel toxins.
Although a clear relationship between PBITx1 and ‘short’
insectotoxins is evident, it is interesting to compare the pri-
mary structure of PBITx1 with those of other basic short-
chain toxins isolated from di¡erent arthropods and from ani-
mals belonging to distinct phyla (Fig. 3). For instance, the
absence of a cysteine pair at positions 19^20 in PBITx1, as-
suming that residue 19 represents an aspartic acid and not a
cysteine residue (see above), contrasts with all other ‘short’
insectotoxins. It is reminiscent of the CxxxC motif in K-KTx
neurotoxins, such as in charybdotoxin (ChTx) from the ven-
om of the scorpion L. quinquestriatus hebraeus [23]. In addi-
tion, sequence alignment of PBITx1 with ChTx, combined
with the introduction of gaps to improve alignment, revealed
sequence identity at seven positions (28%). Likewise, compar-
ison between chlorotoxin and ChTx yields identity at 11 posi-
tions (30.6%) with a fully conserved stretch of residues R25-
G26-K27-C28 residing in one of the L-sheets. Interestingly,
K27, known to be crucially involved in the interaction with
the pore of voltage-gated K channels, forms part of this
stretch of residues. Nevertheless, chlorotoxin block of volt-
age-gated K channels has never been shown so far. In terms
of three-dimensional structure, it is known that all these
‘short’ scorpion peptides have an K-helix bound by two disul-
¢de bridges to the second strand of the antiparallel L-sheet
(see Fig. 2), resulting in very similar sca¡olds. In the case of
‘short’ insectotoxins, a stabilizing role is played by a fourth
disul¢de bridge connecting the N-terminus of the peptide with
the C-terminal part of the K-helix [14^16].
Finally, we have compared the sequences of PBITx1,
chlorotoxin, ChTx and U-conotoxin PVIIA from the venom
of Conus purpurascens [24]. There are several obvious reasons
for such a comparison: (i) a number of sequence identities
exist, which deserve closer examination, (ii) U-conotoxin
PVIIA is the ¢rst cone snail toxin described to block volt-
age-gated K channels [24], and (iii) ChTx is one of the
best characterized scorpion toxins also acting on voltage-
gated K channels (Fig. 3). A search for U-conotoxin se-
quence identity reveals identity at six positions with PBITx1
(24%), 12 positions with chlorotoxin (33%), and nine positions
with ChTx (24.3%). The presence of residues C8-F9 and D13-
D14-C15-C16 in U-conotoxin is noteworthy, because identical
positions can be found in ‘short’ insectotoxins as well. Fur-
thermore, the sequence R18-K19-C20 in U-conotoxin is very
reminiscent of the R25-K27-C28 stretch in ChTx. Some of
these primary structure comparisons may not be functionally
relevant, since it is known that the fold adopted by U-cono-
toxin PVIIA is unrelated to the fold of short-chain toxins
from scorpions [14^16,23,25]. However, in the light of the
hypothesis of convergent evolution of animal toxins, i.e. tox-
ins that have unrelated structures but similar functions thanks
to conserved key functional residues [26], it will be interesting
to see if, for instance, the absence of a conserved diad of
functional residues, such as K27-Y36 in ChTx [26] and K7-
F9 or F23 in U-conotoxin [25], can explain the supposed in-
activity of ‘short’ insectotoxins on voltage-gated K channels.
In the absence of strong experimental evidence at present,
we can only speculate on the biological activity of ‘short’
insectotoxin peptides. Based on the literature evidence, a
block of small-conductance Cl3 channels derived from epithe-
lial cells has been reported for chlorotoxin [17]. The other
‘short’ insectotoxins presumably act on the glutamate receptor
of the postsynaptic membrane, manifesting a paralyzing e¡ect
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Fig. 3. Primary structure comparison between short-chain toxins from scorpion and snail venom. Manual alignment of cysteine residues reveals
identical regions (boxed) between short-chain toxins isolated from scorpion venom, such as ChTx [23], PBITx1 and chlorotoxin [15,17], but
also with U-conotoxin [24,25] which is a toxin isolated from a di¡erent phylum. The pattern of disul¢de bridges is indicated. It is interesting to
note that the fourth disul¢de bridge in chlorotoxin (dashed line) represents an ‘additional’ disul¢de pairing as compared to the pairings in
ChTx.
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on insects [27]. One of the reasons that the biological activity
remains unclear is the scarcity and tiny share of ‘short’ insec-
totoxins in scorpion venom, hampering full characterization
of these peptides. Moreover, it has been claimed that ‘short’
insectotoxins are not part of the scorpion’s natural secretions,
but are found only in venom collected by electrical stimula-
tion [28]. The fact that PBITx1 could only be found in one
puri¢cation round, although all the venoms from P. schlech-
teri were electrically elicited using the same protocol, does not
corroborate the above. Therefore, future experiments, such as
analyzing the genomic organization of sITx genes or chemical
synthesis of sITx peptides, will be needed to shed light on the
biological activity of these interesting molecules.
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